SCHEMBL6348677

SCHEMBL6348677

N#Cc1ccc(NC(=O)c2ccc(-c3ccccc3)cc2)c(C(=O)O)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 4/20 0.66
DHODH Q02127 1/20 0.63
IGF2BP2 Q9Y6M1 1/20 0.58
ALB P02768 1/20 0.57
PDCD1 Q15116 1/20 0.53
CD274 Q9NZQ7 1/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
KMT2A Q03164 3/20 0.53
MAPT P10636 3/20 0.52
MEN1 O00255 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
PKM P14618 1/20 0.52
GRIK1 P39086 1/20 0.52
LTC4S Q16873 1/20 0.52
PTPN1 P18031 1/20 0.51
KDM4E B2RXH2 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
ALDH1A1 P00352 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6353963 0.92 KMT2A (0.62) SERPINE1DHODHALBKMT2AMAPT
SCHEMBL6359401 0.90 ALB (0.63) SERPINE1ALBNPC1RAB9AKMT2A
SCHEMBL6349987 0.90 ALB (0.57) SERPINE1DHODHIGF2BP2ALBNPC1
SCHEMBL6346687 0.88 ALB (0.60) SERPINE1ALBRAB9AKMT2AMAPT
SCHEMBL6357270 0.88 SERPINE1 (0.62) SERPINE1DHODHIGF2BP2ALBKMT2A
SCHEMBL6834385 0.86 SERPINE1 (0.51) SERPINE1DHODHIGF2BP2ALBPDCD1
SCHEMBL6350083 0.86 SERPINE1 (0.68) SERPINE1IGF2BP2ALBNPC1RAB9A
SCHEMBL6833755 0.86 KCNH2 (0.55) SERPINE1DHODHIGF2BP2ALBKMT2A
SCHEMBL6348543 0.85 ALB (0.58) SERPINE1ALBKMT2AMAPTMEN1
SCHEMBL6352338 0.85 KMT2A (0.57) DHODHALBNPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 SERPINE1 1929/4885DHODH 49/4885IGF2BP2 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.